Clearstead Advisors, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Clearstead Advisors, LLC
- $6.31 Billion
- Q3 2024
A detailed history of Clearstead Advisors, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 108 shares of AMPH stock, worth $4,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 108
-0.0%
Holding current value
$4,007
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
36.5MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$221 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$101 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$79.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$72.3 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$59.9 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.82B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...